University of California, Los Angeles
Also known as: Adam de Havenon | Ahmanson / UCLA Adult Congenital Heart Disease Center | Assistant Clinical Professor; University of California, Los Angeles | Brain Tumor Imaging, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA | Center for AIDS Research and Education, University of California, Los Angeles | Center for Human Nutrition, UCLA David Geffen School of Medicine | Clinical Research Director, Ahmanson Translational Theranostics | Cousins Center for Psychoneuroimmunology, University of California, Los Angeles | David Geffen School of Medicine at UCLA, USA | David Geffen School of Medicine, UCLA | David Geffen - UCLA School of Medicine | David Liebeskind | Department of Economics, UCLA | Department of Pediatrics, University of California Los Angeles | Department of Psychiatry, Harbor-UCLA Medical Center, California, U.S.A | Department of Psychiatry, Harbor-UCLA Medical Center, Torrance, California | Department of Psychology, UCLA | Department of Pulmonology and Critical Care at David Geffen School of Medicine at UCLA | Desert Pacific Mental Illness Research Education and Clinical Center Semel Institute for Neuroscience at UCLA | Digestive Health and Nutrition Clinic. University of California, Los Angeles, CA, USA | Division of Pulmonary & Critical Care, Department of Medicine, RM# 37-131 CHS, David Geffen School of Medicine/UCLA. 90095-1690 | Division of Rheumatology, Allergy, and Immunology, University of California, Los Angeles | Division of Rheumatology, Department of Medicine, University of California, Los Angeles | Donald B. Kohn, M.D. | Donald E. Morisky | Dr. Veena Ranganath | Fady M Kaldas, M.D., F.A.C.S. | Geffen School of Medicine, University of California, Los Angeles (UCLA) | General Clinical Research Center - Harbor UCLA Medical center | Harbor UCLA | Harbor-UCLA Medical Center (LABiomed) | Harbor-UCLA Medical Center, Los Angeles Biomedical Research Institute | Harbor-UCLA Research & Education Institute | Institute of Urologic Oncology at UCLA | Jeffrey L. Saver | Jeffrey Veale, MD | Jonsson Comprehensieve Cancer Center | Jonsson Comprehensive Cancer Center | Jules Stein Eye Institute and Harbor-UCLA Medical Center | Jules Stein Eye Institute, University of California Los Angeles | Kern Medical Center | Kern Medical Center, David Geffen School of Medicine, UCLA | Kern Medical Center UCLA | LABioMed at Harbor-UCLA | LaBiomed At Harbor-UCLA Medical Center | LABioMed at Harbor-UCLA Medical Center | LABiomedical Research Institute at Harbor-UCLA Medical Center | LA BioMedical Research Institute, Harbor-UCLA | Los Angeles Biomedical Institute | Los Angeles Biomedical Institute at Harbor-UCLA | Los Angeles BioMedical Research Center at Harbor-UCLA | Los Angeles Biomedical Research Institute at Harbor-UCLA | Los Angeles Biomedical Research Institute at Harbor - University of Los Angeles Medical Center | Los Angeles Biomedical Research Institute (LABioMed) | Los Angeles Orthopaedic Hospital | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | Mary S. Easton Center for Alzheimer's Disease Research at UCLA | Mattel Children's Hospital of UCLA | Meghan Pearl, MD | Michael Irwin, MD | Michael Roth | Neurology, University of California, Los Angeles, USA | Olive View-UCLA Education & Research Institute | Oppenheimer Family Center for Neurobiology of Stress at UCLA | Oppenheimer Family Center of Neurobiology of Stress, UCLA | Paul Finn | Rapoport, Alan, M.D. | Revlon/UCLA Breast Center | Rheumatology Division, UCLA Medical School | Richard C Reznichek, MD | Robert W. Baloh | Ronald Reagan UCLA Medical Center | Ronald Reagan UCLA Medical Center Los Angeles, CA | Semel Institute for Neuroscience and Human Behavior at UCLA | Sharif Medical Research Center | Suzanne Kafaja | The Lundquist Institute For Biomedical Innovation at Harbor-UCLA Medical Center | The Regents of the University of California, Los Angeles | TORL Biotherapeutics, LLC | UCLA AIDS Prevention & Treatment CTU | UCLA and Charles R. Drew University | UCLA Anderson School of Management | UCLA and Western Los Angles VA | UCLA BIOMEDICAL | UCLA CARE Center CRS | UCLA Center for AIDS Research and Educationi | UCLA Center for Clinical AIDS Research and Education | UCLA Center for Human Nutrition | UCLA Center for Neurovisceral Sciences and Women's Health | UCLA Clinical AIDS Research and Education (CARE) Center | UCLA Clinical Professor of Pediatrics | UCLA CURE Digestive Diseases Research Center | UCLA David Geffen School of Medicine | UCLA David Geffen School of Medicine and Fielding School of Public Health | UCLA David Geffen School of Medicine, Division of Rheumatology | UCLA Department of Anesthesiology | UCLA Department of Dermatology | UCLA Department of Family Medicine | UCLA Department of Medicine | UCLA Department of Medicine, Division of Clinical Nutrition | UCLA Department of Molecular and Medical Pharmacology | UCLA Department of Psychiatry and Biobeavioral Sciences | UCLA Department of Psychiatry and Biobehavioral Sciences | UCLA Department of Surgery | UCLA Dept of Family Medicine | UCLA-Dept of Medicine a Div of Hem/Onc | UCLA Dept Surgery | UCLA DGSOM Dept Of Family Medicine | UCLA Division of Cardiology | UCLA Division of Dermatology | UCLA, Division of Hematology/Oncology | UCLA Division of Hematology/oncology, Los Angeles | UCLA Health System | UCLA Hematology/Oncology Parkside | UCLA Integrated Substance Abuse Programs | UCLA JCCC Clinical Research Unit | UCLA / Jonsson Comprehensive Cancer Center | UCLA Jonsson Comprehensive Cancer Center | UCLA/Jonsson Comprehensive Cancer Center | UCLA Jules Stein Eye Institute | UCLA Kidney Transplant Research | UCLA Longevity Center | UCLA Mood Disorders Research Program | UCLA Neurology | UCLA NPI | UCLA Oncology Center | UCLA Professor of Medicine | UCLA Program on Genomics and Nutrition | UCLA Psychiatry & Biobehavioral Sciences | UCLA Pulmonary Division | UCLA School of Medicine, Study Overall Principal Investigator | UCLA School of Nursing | UCLA School of Public Health | UCLA Semel | UCLA Semel Institute | UCLA Stroke Center | UCLA Stroke Center, Co-Principal Investigator | UCLA - TORI | UCLA Vatche and Tamar Manoukian Division of Digestive Diseases | UCLA Vice Street Clinic | unaffiliated (Assistant Clinical Professor of Medicine, David Geffen School of Medicine at UCLA) | UNIV CALIFORNIA LOS ANGELES | UNIV CA LOS ANGELES | Univeristy of California, Los Angeles | University California, Los Angeles | University of California at Los Angeles | University of California at Los Angeles (UCLA ) | University of California at Los Angeles (UCLA) | University of California at Los Angeles, UCLA | University of California Geffen School of Medicine | University of California, in Los Angeles, Division of Rheumatology, 310 206 7866 | University of California, Los Angeles | Universityof California Los Angeles | University of California, Los Angeles, California, USA | University of California, Los Angeles; Center for the Health Sciences | University of California Los Angeles David Geffen School of Medicine | University of California Los Angeles, Department of Neurosurgery | University of California, Los Angeles, Department of Neurosurgery | University of California, Los Angeles Department of Orhtopaedic Surgery | University of California, Los Angeles, Department of Psychiatry and Biobehavioral Sciences | University of California, Los Angeles, Neuropsychiatric Institute | University of California, Los Angeles - Pulmonary Division | University of California, Los Angeles (UCLA) | University of California, Los Angeles (UCLA), Los Angeles, CA | University of California, Los Angeles (UCLA) Semel Institute for Neuroscience and Human Behavior | University of California , Los Angeles, USA | University of Southern California, Los Angeles | VA Los Angeles/UCLA | Walter Ling | Zachary A. Rubin, MD | Zhaoping Li
Highest phase reached
Phase 4
First clinical trial
Mar 1, 1990First marketed drug
Jun 27, 2013First NDA
Dec 1, 2020Last known activity
Apr 30, 2026
Timeline
1910s
- Jan 1, 1919
University of California, Los Angeles— Founded
2010s
- Jun 27, 2013
ammonia n-13— Marketing Organization
2020s
- Dec 1, 2020
Ga 68 PSMA-11— NDA Organization
- Dec 1, 2020
Ga 68 PSMA-11— NDA Secondary Org
Drugs by trial phase (747 distinct, 956 trials)
Phase 4 (140 own, 0 via acquisition)
Phase 3 (133 own, 0 via acquisition)
Phase 2 (286 own, 0 via acquisition)
Phase 1 (126 own, 0 via acquisition)
- myrcene
- vcp205
- Filgrastim
- segesterone
- vasopressin
- torl-3-600
- adgmcaix-transduced autologous dendritic cells
- naproxen
- il13ralpha2-specific hinge-optimized 4-1bb-co-stimulatory car/truncated cd19-expressing autologous tn/mem cells (Biological)
- midodrine
- beta-caryophyllene
- av608
- pr-104
- torl-2-307-adc
- cannabis
- +111 more
Indications
Studied for
- Abortion, Missed
- Abortion, Spontaneous
- Abscess
- Acidosis
- Acne Vulgaris
- Acquired Immunodeficiency Syndrome
- ACTH-Secreting Pituitary Adenoma
- Acute Kidney Injury
- Acute Pain
- Addison Disease
- Adenocarcinoma
- Adenomyosis
- Adenoviridae Infections
- Adrenal Gland Neoplasms
- Adrenal Insufficiency
- Adrenoleukodystrophy
- AIDS Dementia Complex
- Alcohol Drinking
- Alcoholism
- Alzheimer Disease
- Amino Acid Metabolism, Inborn Errors
- Amphetamine-Related Disorders
- Anemia
- Anemia, Aplastic
- Anemia, Sickle Cell
- Anhedonia
- Anterior Cruciate Ligament Injuries
- Anxiety Disorders
- Appendicitis
- Arteriosclerosis
- Arthritis
- Arthritis, Rheumatoid
- Asthenozoospermia
- Asthma
- Astrocytoma
- Ataxia
- Atherosclerosis
- Attention Deficit Disorder with Hyperactivity
- Autism Spectrum Disorder
- Autistic Disorder
- Autoimmune Diseases
- Behavior, Addictive
- Bile Duct Neoplasms
- Bipolar Disorder
- Birth Weight
- Blast Crisis
- Blindness
- Body Dysmorphic Disorders
- Brachial Plexus Neuritis
- Brain Diseases
- Brain Injuries
- Brain Injuries, Traumatic
- Brain Neoplasms
- Breast Carcinoma In Situ
- Breast Neoplasms
- Breast Neoplasms, Male
- Bronchitis
- Bronchitis, Chronic
- Bronchopulmonary Dysplasia
- Cachexia
- Calcinosis
- Carbamoyl-Phosphate Synthase I Deficiency Disease
- Carcinoma
- Carcinoma, Ductal
- Carcinoma, Hepatocellular
- Carcinoma in Situ
- Carcinoma, Neuroendocrine
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Renal Cell
- Carcinoma, Small Cell
- Carcinoma, Squamous Cell
- Carcinoma, Transitional Cell
- Carcinoma, Verrucous
- Cardiovascular Abnormalities
- Cardiovascular Diseases
- Carotid Body Tumor
- Cellulitis
- Central Nervous System Neoplasms
- Cerebellar Ataxia
- Cerebral Hemorrhage
- Cerebral Palsy
- Child Development Disorders, Pervasive
- Cholangiocarcinoma
- Cholestasis
- Chordoma
- Chronic Disease
- Chronic Kidney Disease-Mineral and Bone Disorder
- Chronic Pain
- Cicatrix
- Clostridium Infections
- Cocaine-Related Disorders
- Coccidioidomycosis
- Coccidiosis
- Cognition Disorders
- Cognitive Dysfunction
- Colonic Neoplasms
- Colorectal Neoplasms
- Communicable Diseases
- Compulsive Personality Disorder
Marketed drugs (3)
Recent trials (50)
- NCT03386071Overall official - principal investigatorN/A—
- NCT03386071Lead sponsorN/A—
- NCT03386071OfficialN/A—
- NCT04437004Sponsor investigatorN/A—
- NCT04437004Lead sponsorN/A—
- NCT07191717OfficialPhase 2Apr 30, 2026
- NCT07191717Lead sponsorPhase 2Apr 30, 2026
- NCT07251985Sponsor investigatorPhase 2Feb 1, 2026
- NCT07251985Lead sponsorPhase 2Feb 1, 2026
- NCT07251985OfficialPhase 2Feb 1, 2026
- NCT07269041CollaboratorPhase 1/Phase 2Jan 31, 2026
- NCT07269041Lead sponsorPhase 1/Phase 2Jan 31, 2026
- NCT07269041OfficialPhase 1/Phase 2Jan 31, 2026
- NCT07269041Sponsor investigatorPhase 1/Phase 2Jan 31, 2026
- NCT06701760Lead sponsorPhase 2Jan 5, 2026
Details
- Founded
- Los Angeles, California, US Jan 1, 1919
- First NDA
- Dec 1, 2020
- Last known activity
- Apr 30, 2026